Ending TB is a Race Against Time and Drug Resistance

Twenty-nine countries in the EU/EEA reported a total of 47,504 TB cases, which equates to a rate of 9.2 cases per 100,000. Across the EU/EEA, most country-specific rates continue to decline; however, the EU/EEA as a whole is currently not on track to reach the goal of ending TB by 2030. Courtesy of the ECDC

The tuberculosis (TB) burden in the WHO European Region as a whole is decreasing, and is down 19% overall for 2015-2019, according to the latest WHO/European Centre for Disease Prevention and Control (ECDC) report Tuberculosis surveillance and monitoring in Europe 2021 (2019 data).

Regional TB mortality has gone down, declining by 9.4% between 2018 and 2019. This is notably higher than the average global decline in TB mortality (3.7%) and enough to have reached the End TB Strategy milestone of a 35% reduction by 2020 compared to 2015.

However, TB is second only to COVID-19 as an infectious disease that kills, and drug resistance is a major concern. There are also worrying indications that the COVID-19 pandemic may stall progress or cause significant setbacks in the fight against TB.

In 2019, there were an estimated 20,000 TB deaths in the WHO European Region -- equivalent to 2.2 deaths per 100,000 people, and some 3,560 TB deaths occurred in the European Union/European Economic Area (EU/EEA), equal to 0.7 deaths per 100,000. For 2019, in the European Region as a whole, there were some 216,000 new TB diagnoses, corresponding to 23.2 cases per 100,000.

Twenty-nine countries in the EU/EEA reported a total of 47,504 TB cases, which equates to a rate of 9.2 cases per 100,000. Across the EU/EEA, most country-specific rates continue to decline; however, the EU/EEA as a whole is currently not on track to reach the goal of ending TB by 2030.

TB is far from being evenly distributed in the European Region. Around 83% of estimated cases occur in 18 countries, where incidence is five times higher than the EU/EEA average. Five of the 18 high priority countries are within the EU/EEA, and 13 are in eastern Europe and central Asia.

The decrease in TB burden put the Region on course to reach the End TB Strategy milestone for 2020 and the regional action plan target for reduction of the TB incidence rate. However, there are grave concerns that the COVID-19 pandemic may jeopardize recent progress.

Negative impacts have already been observed in TB service delivery and notifications in high-burden countries, this is believed to indicate that fewer people have been tested, meaning that people with undiagnosed TB are not getting the treatment they need and run the risk of infecting others.

The findings of an ongoing assessment of the impact of COVID-19 on TB services and spread in the European Region, will be ready in the spring of 2021.

Despite universal access to quality-assured anti-TB drugs, treatment outcomes in the Region remain sub-optimal. Only 77% of patients successfully completed treatment in 2019, well below the global rate of 85%. Treatment success in the EU/EEA was lower still, with only 64% of all TB cases notified in 2018 being reported as having completed their treatment successfully.

Strains of TB that do not respond to commonly used treatment regimens are known as either multidrug-resistant tuberculosis (MDR-TB) or extensively drug-resistant tuberculosis (XDR-TB). Just 59% of MDR-TB cases notified in the Region in 2017 were successfully treated, far short of the 75% target. As for XDR-TB cases in 2016, treatment success was only 43%.

Across the Region, treatment outcomes for MDR-TB remain suboptimal. Unsuccessful treatment is one of the factors that drives resistance, often due to lack of effective TB medicines in treatment regimens for drug-resistant TB, and low adherence to therapy.

Overall, in the Region, every third pulmonary TB patient has a drug-resistant form of the disease. Across the Region, a quarter of drug-resistant TB patients have XDR-TB, and 70% of the world's XDR-TB patients live in the European Region.

The percentage of newly notified TB patients tested using WHO-recommended rapid diagnostic tests increased from 45% in 2015 to 69% in 2019, but nonetheless remains below the global End TB Strategy target of 90%. Rapid diagnostic tests allow quicker diagnosis, resulting in minimization of suffering, onward transmission and death.

People living with HIV are particularly susceptible to TB, and coinfection is common. In the European Region, only 52% of coinfected patients complete TB treatment successfully, far below the global rate of 76%. This means that in the European Region there is a lower probability of people with a coinfection being successfully treated and making a full recovery.

Stella Kyriakides, European Commissioner for Health and Food Safety stated, "The decline of tuberculosis in recent years is positive news. But TB continues to be a threat to some regions in the EU and continues to affect the most vulnerable in our society. We know that there is still more work to do. Together with our agencies, the Commission is committed to playing its part to eliminate TB through, in part, funding, research and the fight against antimicrobial resistance. Prevention, early diagnosis and access to treatment and care will also play key roles in this regard."

ECDC director Dr. Andrea Ammon commented, "In the EU/EEA, the overall TB notification rate continued to fall in 2019, highlighting some progress towards the United Nations Sustainable Development Goals (SDGs). However, despite this progress, the EU/EEA is not currently on track to reach the goal of ending the TB epidemic by 2030. Further to this, across all cohorts, treatment success in the EU/EEA remains well below the WHO targets. The wide-scale disruption to TB services due to the COVID-19 pandemic will make it even more difficult for Member States to reach the SDGs and treatment targets, but now is the time for countries to accelerate their progress towards eliminating TB."

Read the full report: https://www.ecdc.europa.eu/en/publications-data/tuberculosis-surveillance-and-monitoring-europe-2021-2019-data

Source: ECDC

69 Comments on "Ending TB is a Race Against Time and Drug Resistance"

  1. Thx so much !! Appreciate the helpful info.

  2. I appreciate the information.

  3. Good info. Lucky me I came across your blog by accident (stumbleupon). I have book marked it for later.

  4. hello there and thank you for your information ?I have
    definitely picked up something new from right here.
    I did however expertise some technical points using this website, as I experienced to rreload the web site a
    lot of times previous to I could get it to load
    properly. I had been wondering if your hosting iss OK?
    Not that I’m complaining, buut slow lading instances times will very frequently afftect your
    placement in google and can damage your high quality scoore if adss and marketing with
    Adwords. Anywsy I am adding this RSS tto my e-mail and could look
    out for much more of your respective fasxcinating content.
    Ensure that you update this again very soon.. https://www.authorstream.com/armbobcat29/

  5. helpo there and thank you for your information ?
    I have definitely picked up something new from right here. I did however
    expertise some technical points using this website,
    as I experienced to reload the wweb site a lot
    off times previous to I could get it to
    load properly. I had been wondering if your hosting is OK?
    Not tgat I’m complaining, butt slow loading instances times will very frequently affect your placement in google and can damagye your
    high quality score if ads and marketing with Adwords.
    Anyway I am adding this RSS to my e-mail and could look out for
    much more of your respective fascinating content. Ensure that you update this again very
    soon.. https://www.authorstream.com/armbobcat29/

  6. You are a great writer. Do you have any more webpages?

  7. Great web site you’ve got here.. It’s difficult to find high-quality writing like yours nowadays. I really appreciate individuals like you! Take care!!

  8. Thank very much for helping me.

  9. This website definitely has all of the information and facts I needed concerning this subject and didn’t know who to ask.

  10. I am interested in more info. How can I contact you?

  11. Having read this I thought it was very informative. I appreciate you taking the time and energy to put this informative article together. I once again find myself personally spending a lot of time both reading and commenting. But so what, it was still worth it!

  12. I am interested in more info. How can I reach you?

  13. Aw, this was an exceptionally nice post. Taking the time and actual effort to produce a top notch article… but what can I say… I hesitate a whole lot and never manage to get nearly anything done.

  14. Very good information thanks so much!

  15. Thank very much for helping me.

  16. Very good info thanks so much!

  17. I am a mother looking to talk.

  18. Thank very much for helping me.

  19. Good write-up. I definitely love this website. Thanks!

  20. This information is so amazing thanks!

  21. Just wanted to say thanks!

  22. Interested in more info. How can I contact you?

  23. You are a great writer. Do you have any more sites?

  24. I really admire your writing!

  25. You are a great writer. Do you have any more websites?

  26. How can I get more helpful info?

  27. It’s nearly impossible to find educated people on this subject, but you seem like you know what you’re talking about! Thanks

  28. Appreciate the helpful info

  29. I really like your writing!

  30. I am a adult female looking to talk.

  31. I am a older women looking to chat.

  32. The very next time I read a blog, I hope that it doesn’t fail me as much as this particular one. After all, Yes, it was my choice to read, nonetheless I really believed you would have something helpful to talk about. All I hear is a bunch of whining about something you could fix if you were not too busy seeking attention.

  33. How can I contact you? I am interested in more info.

  34. I don’t even know the way I stopped up right here, however I thought
    this put up used to be great. I do not realize who you might be but
    definitely you are going to a well-known blogger when you are not already.
    Cheers!

  35. Thanks so much for your hard work.

  36. Thank you for sharing.

  37. How can I reach you? I am interested in more information.

  38. How can I contact you? I am interested in more info.

  39. Appreciate the helpful information

  40. How can I get more helpful information?

  41. Everything is very open with a precise explanation of the issues. It was definitely informative. Your website is very helpful. Thank you for sharing.

  42. Oh my goodness! Awesome article dude! Thanks, However I am experiencing troubles with your RSS. I don’t understand the reason why I can’t subscribe to it. Is there anybody else getting similar RSS issues? Anybody who knows the answer will you kindly respond? Thanx.

  43. man of steel male enhancement pills

  44. Appreciate the helpful information

  45. rhino products male enhancement

Leave a comment

Your email address will not be published.


*